Pharmaceutically active combination
US5126134A · kind A · utility
15Cited by
2References
34Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 18, 1989 |
| Grant date | Jun 30, 1992 |
| Priority date | — |
| Expiry date | Sep 18, 2009 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a pharmaceutical composition comprising as component A a plasminogen activator and as component B hirudin together with a pharmaceutically acceptable carrier. The pharmaceutical composition can be used for the prophylaxis and therapy of thrombosis or diseases caused by thrombosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.